Tuesday, 5 June 2012

Webinar: New approaches to treating inflammation in Duchenne - PPMD Community

Webinar: New approaches to treating inflammation in Duchenne - PPMD Community: Parent Project Muscular Dystrophy�welcomes Dr. Michael Jirousek from�Catabasis�as our guest for a webinar on June 6, 2012 at 1pm eastern.*

Topic:�New approaches to treating inflammation in Duchenne
When:�Wednesday,�June 6, 1pm eastern

Inflammation is a key pathway in the disease pathway in Duchenne’s muscular dystrophy. CAT-1004 is a novel, anti-inflammatory agent being developed by Catabasis as a potential treatment for patients with Duchenne. This presentation will describe the science and rationale behind the development program.

No comments:

Post a comment